Skip to Main Content

Paper Details

Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
Cancers (Basel)
13
2021
Author NameAffiliation
Vince D CataldoMary Bird Perkins-Our Lady of the Lake Cancer Center
Pavlos MsaouelThe University of Texas MD Anderson Cancer Center
Pavlos MsaouelThe University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2